カテゴリー： QYResearch, 世界

良性前立腺過形成の治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Benign Prostatic Hyperplasia Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18219）・商品コード：DATA909X18219
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：130
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、良性前立腺過形成の治療の世界市場について調査・分析し、良性前立腺過形成の治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物クラス、低侵襲手術、レーザー治療、その他）、用途別（病院、外来手術センター、専門クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の良性前立腺過形成の治療市場動向
・主要企業別マーケットシェア
・良性前立腺過形成の治療の種類別市場規模2014-2019
（薬物クラス、低侵襲手術、レーザー治療、その他）
・良性前立腺過形成の治療の用途別市場規模2014-2019
（病院、外来手術センター、専門クリニック、その他）
・良性前立腺過形成の治療の北米市場：主要企業・種類別/用途別市場規模
・良性前立腺過形成の治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・良性前立腺過形成の治療の中国市場：主要企業・種類別/用途別市場規模
・良性前立腺過形成の治療の日本国内市場：主要企業・種類別/用途別市場規模
・良性前立腺過形成の治療の東南アジア市場：主要企業・種類別/用途別市場規模
・良性前立腺過形成の治療のインド市場：主要企業・種類別/用途別市場規模
・良性前立腺過形成の治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Abbott、Allergan plc、Astellas Pharma、Asahi Kasei Corporation、Boehringer Ingelheim GmbH、GlaxoSmithKline、Pfizer、Sanofi、Teva Pharmaceutical Industries、Merck、Boston Scientific Corporation、Teleflex Incorporated、Endo International、Urologix、LISA Laser、Olympus）
・良性前立腺過形成の治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

In 2018, the global Benign Prostatic Hyperplasia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Benign Prostatic Hyperplasia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Benign Prostatic Hyperplasia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott
Allergan plc
Astellas Pharma
Asahi Kasei Corporation
Boehringer Ingelheim GmbH
GlaxoSmithKline
Pfizer
Sanofi
Teva Pharmaceutical Industries
Merck
Boston Scientific Corporation
Teleflex Incorporated
Endo International
Urologix
LISA Laser
Olympus

Market segment by Type, the product can be split into
Drug Class
Minimally Invasive Surgeries
Laser Therapy
Others

Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Benign Prostatic Hyperplasia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Benign Prostatic Hyperplasia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Benign Prostatic Hyperplasia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Drug Class
1.4.3 Minimally Invasive Surgeries
1.4.4 Laser Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Benign Prostatic Hyperplasia Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Specialty Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Benign Prostatic Hyperplasia Treatment Market Size
2.2 Benign Prostatic Hyperplasia Treatment Growth Trends by Regions
2.2.1 Benign Prostatic Hyperplasia Treatment Market Size by Regions (2019-2025)
2.2.2 Benign Prostatic Hyperplasia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Benign Prostatic Hyperplasia Treatment Market Size by by Players
3.1.1 Global Benign Prostatic Hyperplasia Treatment Revenue by by Players (2014-2019)
3.1.2 Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Benign Prostatic Hyperplasia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Benign Prostatic Hyperplasia Treatment Key Players Head office and Area Served
3.3 Key Players Benign Prostatic Hyperplasia Treatment Product/Solution/Service
3.4 Date of Enter into Benign Prostatic Hyperplasia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Benign Prostatic Hyperplasia Treatment Market Size by Type (2014-2019)
4.2 Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
5.2 Benign Prostatic Hyperplasia Treatment Key Players in North America
5.3 North America Benign Prostatic Hyperplasia Treatment Market Size by Type
5.4 North America Benign Prostatic Hyperplasia Treatment Market Size by Application

6 Europe
6.1 Europe Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
6.2 Benign Prostatic Hyperplasia Treatment Key Players in Europe
6.3 Europe Benign Prostatic Hyperplasia Treatment Market Size by Type
6.4 Europe Benign Prostatic Hyperplasia Treatment Market Size by Application

7 China
7.1 China Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
7.2 Benign Prostatic Hyperplasia Treatment Key Players in China
7.3 China Benign Prostatic Hyperplasia Treatment Market Size by Type
7.4 China Benign Prostatic Hyperplasia Treatment Market Size by Application

8 Japan
8.1 Japan Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
8.2 Benign Prostatic Hyperplasia Treatment Key Players in Japan
8.3 Japan Benign Prostatic Hyperplasia Treatment Market Size by Type
8.4 Japan Benign Prostatic Hyperplasia Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
9.2 Benign Prostatic Hyperplasia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size by Type
9.4 Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size by Application

10 India
10.1 India Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
10.2 Benign Prostatic Hyperplasia Treatment Key Players in India
10.3 India Benign Prostatic Hyperplasia Treatment Market Size by Type
10.4 India Benign Prostatic Hyperplasia Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Benign Prostatic Hyperplasia Treatment Market Size (2014-2019)
11.2 Benign Prostatic Hyperplasia Treatment Key Players in Central & South America
11.3 Central & South America Benign Prostatic Hyperplasia Treatment Market Size by Type
11.4 Central & South America Benign Prostatic Hyperplasia Treatment Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Benign Prostatic Hyperplasia Treatment Introduction
12.1.4 Abbott Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019))
12.1.5 Abbott Recent Development
12.2 Allergan plc
12.2.1 Allergan plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Benign Prostatic Hyperplasia Treatment Introduction
12.2.4 Allergan plc Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.2.5 Allergan plc Recent Development
12.3 Astellas Pharma
12.3.1 Astellas Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Benign Prostatic Hyperplasia Treatment Introduction
12.3.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.3.5 Astellas Pharma Recent Development
12.4 Asahi Kasei Corporation
12.4.1 Asahi Kasei Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Benign Prostatic Hyperplasia Treatment Introduction
12.4.4 Asahi Kasei Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.4.5 Asahi Kasei Corporation Recent Development
12.5 Boehringer Ingelheim GmbH
12.5.1 Boehringer Ingelheim GmbH Company Details
12.5.2 Company Description and Business Overview
12.5.3 Benign Prostatic Hyperplasia Treatment Introduction
12.5.4 Boehringer Ingelheim GmbH Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.5.5 Boehringer Ingelheim GmbH Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Benign Prostatic Hyperplasia Treatment Introduction
12.6.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Benign Prostatic Hyperplasia Treatment Introduction
12.7.4 Pfizer Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Sanofi
12.8.1 Sanofi Company Details
12.8.2 Company Description and Business Overview
12.8.3 Benign Prostatic Hyperplasia Treatment Introduction
12.8.4 Sanofi Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.8.5 Sanofi Recent Development
12.9 Teva Pharmaceutical Industries
12.9.1 Teva Pharmaceutical Industries Company Details
12.9.2 Company Description and Business Overview
12.9.3 Benign Prostatic Hyperplasia Treatment Introduction
12.9.4 Teva Pharmaceutical Industries Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.9.5 Teva Pharmaceutical Industries Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Benign Prostatic Hyperplasia Treatment Introduction
12.10.4 Merck Revenue in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Boston Scientific Corporation
12.12 Teleflex Incorporated
12.13 Endo International
12.14 Urologix
12.15 LISA Laser
12.16 Olympus

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Benign Prostatic Hyperplasia Treatment Key Market Segments
Table Key Players Benign Prostatic Hyperplasia Treatment Covered
Table Global Benign Prostatic Hyperplasia Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Drug Class Figures
Table Key Players of Drug Class
Figuer Minimally Invasive Surgeries Figures
Table Key Players of Minimally Invasive Surgeries
Figuer Laser Therapy Figures
Table Key Players of Laser Therapy
Figuer Others Figures
Table Key Players of Others
Table Global Benign Prostatic Hyperplasia Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Benign Prostatic Hyperplasia Treatment Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Specialty Clinics Case Studies
Figure Others Case Studies
Figure Benign Prostatic Hyperplasia Treatment Report Years Considered
Figure Global Benign Prostatic Hyperplasia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Benign Prostatic Hyperplasia Treatment Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Treatment Market Share by Regions 2014-2019
Figure Global Benign Prostatic Hyperplasia Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Benign Prostatic Hyperplasia Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Treatment Market Share by by Players (2014-2019)
Figure Global Benign Prostatic Hyperplasia Treatment Market Share by by Players in 2018
Table Global Benign Prostatic Hyperplasia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Benign Prostatic Hyperplasia Treatment Product/Solution/Service
Table Date of Enter into Benign Prostatic Hyperplasia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Treatment Market Size Share by Type (2014-2019)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size Market Share by Type (2014-2019)
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Benign Prostatic Hyperplasia Treatment Market Size Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia Treatment Revenue Market Share by Application in 2018
Figure North America Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table North America Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table North America Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Figure Europe Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table Europe Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table Europe Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Figure China Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table China Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table China Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table China Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table China Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Figure Japan Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table Japan Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table Japan Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Figure India Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table India Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table India Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table India Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table India Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Figure Central & South America Benign Prostatic Hyperplasia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Benign Prostatic Hyperplasia Treatment Market Share (2018-2019)
Table Central & South America Benign Prostatic Hyperplasia Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Treatment Market Share by Type 2014-2019
Table Central & South America Benign Prostatic Hyperplasia Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Benign Prostatic Hyperplasia Treatment Market Share by Application 2014-2019
Table Abbott Company Details
Table Abbott Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Abbott Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Abbott Recent Development
Table Allergan plc Company Details
Table Allergan plc Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Allergan plc Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Allergan plc Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Asahi Kasei Corporation Company Details
Table Asahi Kasei Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Asahi Kasei Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Asahi Kasei Corporation Recent Development
Table Boehringer Ingelheim GmbH Company Details
Table Boehringer Ingelheim GmbH Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Boehringer Ingelheim GmbH Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Boehringer Ingelheim GmbH Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Merck Company Details
Table Merck Revenue in Benign Prostatic Hyperplasia Treatment Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2014-2019)
Table Merck Recent Development
Table Boston Scientific Corporation Company Details
Table Teleflex Incorporated Company Details
Table Endo International Company Details
Table Urologix Company Details
Table LISA Laser Company Details
Table Olympus Company Details
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Benign Prostatic Hyperplasia Treatment Market Size Share by Regions (2019-2025)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size Share by Regions in 2025
Figure North America Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Benign Prostatic Hyperplasia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size by Product (2019-2025)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size by Product in 2025
Table Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2019-2025)
Figure Global Benign Prostatic Hyperplasia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abbott、Allergan plc、Astellas Pharma、Asahi Kasei Corporation、Boehringer Ingelheim GmbH、GlaxoSmithKline、Pfizer、Sanofi、Teva Pharmaceutical Industries、Merck、Boston Scientific Corporation、Teleflex Incorporated、Endo International、Urologix、LISA Laser、Olympus

★調査レポート[良性前立腺過形成の治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18219)販売に関する免責事項を必ずご確認ください。
★調査レポート[良性前立腺過形成の治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 胆道閉鎖症治療の世界市場：規模・現状・予測2019-2025
    DATA909X18226 / QYResearch / 2019年11月25日 / ※当調査レポートでは、胆道閉鎖症治療の世界市場について調査・分析し、胆道閉鎖症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の胆道閉鎖症治療市場動向 ・主要企業別マーケットシェア ・胆道閉鎖症治療の種類別市場規模2014-2019 （薬物治療、外科治療） ・胆道閉鎖症治療の用途別市場規模2014-2019 （病院、診療所、その他） ・胆道閉鎖症治療の北米市場：主要企業・種類別/用途別市場規模 ・胆道閉鎖症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.In 2018, the global Biliary Atresia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary...
  • 悪性腹水治療の世界市場：規模・現状・予測2019-2025
    DATA909X18661 / QYResearch / 2019年11月25日 / ※当調査レポートでは、悪性腹水治療の世界市場について調査・分析し、悪性腹水治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（穿刺、化学療法、外科的治療）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の悪性腹水治療市場動向 ・主要企業別マーケットシェア ・悪性腹水治療の種類別市場規模2014-2019 （穿刺、化学療法、外科的治療） ・悪性腹水治療の用途別市場規模2014-2019 （病院、クリニック、その他） ・悪性腹水治療の北米市場：主要企業・種類別/用途別市場規模 ・悪性腹水治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Ascites are characterized by excess fluid formation in the abdominal cavity, especially in the peritoneal cavity. It causes the body to lose fluids. When ascites develop due to cancer, it is called malignant peritoneal effusion or malignant ascites.In 2018, the global Malignant Ascites Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Malignant Ascites Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Malignant Ascites Treatment...
  • シロアリ駆除の世界市場：規模・現状・予測2019-2025
    DATA909X19024 / QYResearch / 2019年11月25日 / ※当調査レポートでは、シロアリ駆除の世界市場について調査・分析し、シロアリ駆除の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非化学的駆除、化学的駆除）、用途別（商業、住宅、産業、農業）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のシロアリ駆除市場動向 ・主要企業別マーケットシェア ・シロアリ駆除の種類別市場規模2014-2019 （非化学的駆除、化学的駆除） ・シロアリ駆除の用途別市場規模2014-2019 （商業、住宅、産業、農業） ・シロアリ駆除の北米市場：主要企業・種類別/用途別市場規模 ・シロアリ駆除のヨーロッパ市場：主要企業・種類別/用途別市場規模...A defined liquid termite treatment, using an approved termiticide, requires you to trench and treat the foundation, drill and treat all slabs touching the house, drill and treat the front stoop on basement home and treat around the piers in a crawl space.In 2018, the global Termite Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Termite Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the...

    • ◆H&Iグローバルリサーチのお客様（例）◆